Spinal cord glioma
diseaseOn this page
Also known as glial neoplasm spinal cordglial tumor of spinal cordglial tumour of spinal cordmalignant glioma of spinal cordspinal cord glial neoplasmspinal cord glial tumorspinal cord glial tumourspinal cord malignant glioma
Summary
Spinal cord glioma (MONDO:0002542) is a cancer and 1 clinical trial. Top therapeutic interventions include onc-206. A subtype of spinal cord cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 1
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | spinal cord glioma |
| Mondo ID | MONDO:0002542 |
| DOID | DOID:3185 |
| NCIT | C4534 |
| SNOMED CT | 254946004 |
| UMLS | C2937245 |
| MedGen | 423646 |
| GARD | 0023158 |
| Anatomy (UBERON) | UBERON:0002240 |
| Is cancer (heuristic) | yes |
Also known as: glial neoplasm spinal cord · glial tumor of spinal cord · glial tumour of spinal cord · malignant glioma of spinal cord · spinal cord glial neoplasm · spinal cord glial tumor · spinal cord glial tumour · spinal cord glioma · spinal cord malignant glioma
Data availability: 1 cell line.
Disease family
This is a subtype of spinal cord cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › nervous system cancer › central nervous system cancer › spinal cord cancer › spinal cord glioma
Related subtypes (7): spinal cord lymphoma, spinal cord melanoma, spinal cord sarcoma, spinal cord neuroblastoma, spinal meninges cancer, spinal cord primitive neuroectodermal tumor, metastatic malignant neoplasm in the spinal cord
Subtypes (4): spinal cord oligodendroglioma, spinal cord astrocytoma, adult spinal cord glioblastoma, ependymal tumor of spinal cord
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT04732065 | PHASE1 | RECRUITING | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| ONC-206 | 1 | 1 |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.